Natural killer cell

From WikiMD's WELLNESSPEDIA

(Redirected from Natural killer cells)

Natural Killer (NK) cells are a distinct type of lymphocyte that play a key role in the body's innate immune system. Their primary function is to rapidly respond to virus-infected cells and tumor cells. Unique among immune cells, they do not require activation to kill cells that are missing "self" markers of major histocompatibility complex (MHC) class I proteins.

File:Human Natural Killer Cell (29120480442).jpg
Human Natural Killer Cell (29120480442)

Overview[edit]

NK cells, originally named for their ability to kill tumor cells without prior sensitization, are produced in the bone marrow, lymph nodes, spleen, tonsils, and thymus. They represent a minority of circulating lymphocytes, yet they serve as a crucial first line of defense against pathogens and transformed cells.

Function[edit]

  • NK cells work in multiple ways to defend the body. Their primary functions include:
  • Cytotoxicity: NK cells are equipped with granules containing enzymes such as perforin and granzymes. Upon identifying a target cell, NK cells attach and release these enzymes, leading to the death of the target cell.
  • Cytokine production: NK cells can produce numerous cytokines and chemokines, including interferon-gamma (IFN-γ), which helps to modulate the immune response.
  • Immune regulation: NK cells can also influence the adaptive immune response by interacting with other immune cells like dendritic cells, macrophages, and T cells.

NK Cell Receptors[edit]

NK cells have numerous receptors that recognize various signals, including stress-induced ligands and viral proteins. These receptors can either inhibit or activate NK cell function depending on the signals they receive. The balance of these inhibitory and activating signals regulates the activity of the NK cell.

Clinical Implications[edit]

  • NK cells are of significant interest in the fields of oncology, infectious diseases, and transplantation due to their potent cytotoxic capabilities and their potential for modulation.
  • In oncology, therapies that enhance NK cell activity are being investigated for potential anticancer treatments. NK cells' ability to kill tumor cells without prior sensitization makes them appealing in this regard.
  • In infectious diseases, NK cells can contribute to the control of viral infections by directly killing infected cells and by producing IFN-γ.
  • In transplantation, understanding and manipulating NK cell function can improve transplant outcomes. Specifically, they can help prevent graft-versus-host disease in hematopoietic stem cell transplantation and can also prevent graft rejection.

References[edit]